Latin America Protein A Resins Market

Latin America Protein A Resins Market Size (2022 to 2027)

The Protein A Resins Market size in Latin America was worth USD 64.22 million in 2022 and is estimated to be growing at a CAGR of 8.7% to reach USD 97.46 million by 2027.

The Latin American Protein A Resins market is projected to be fuelled by the Factors such as the growing biosimilar demand and increased biosimilar product research and development investments. In addition, the rising demand for biosimilars and growing expenditure in the production of biosimilar goods are expected to fuel the market growth.

Other factors such as the Increased awareness of alternate ways to purifying, presence of key market players, and favorable reimbursement policies are propelling the market growth. During the forecast period, the Latin America region, on the other hand, is expected to grow rapidly owing to the presence of prominent market companies in the region.

However, the high prices have a negative influence on market expansion since they affect affordability and the rate at which protein A resin is adopted. Thus, another significant barrier to market development is the expensive cost of Protein A resin. In addition, alternative purification technologies such as ultrafiltration, crystallization, high-pressure folding, and capillary electrophoresis are limiting the market's growth rate.

This research report on the Latin America Protein A Resins market has been segmented and sub-segmented into the following categories:

By Product Type: 

• Natural Protein A Resin
• Recombinant Protein A Resin

By Application: 

• Immunoprecipitation
• Antibody Purification

By Matrix Type: 

• Glass or Silica
• Agarose
• Organic Polymer  

By End Users: 

• Biopharmaceutical Manufacturers
• Clinical Research Laboratories
• Academic Institutions

By Country: 

• Mexico
• Brazil
• Argentina
• Chile
• Rest of Latin America

The Latin American Protein A resins market is expected to record a substantial share in the global market during the forecast period. Improving healthcare infrastructure, increasing healthcare expenditure, and supportive government policies are propelling market growth. However, Protein A resin sales are expected to rise in the future due to more significant monoclonal antibody research and development. Moreover, the prominent presence of significant pharmaceutical and biotechnological firms in the region and increased funding by government organizations for significant research programs related to protein A resins in the region are likely to augment the market growth. The major growth contributors in the region are Brazil, Mexico, and Argentina.

Brazil dominated the Latin American Protein A resins market in 2020, and it is likely to continue its growth throughout the forecast period. Higher awareness about Purify monoclonal antibodies, rising demand for biosimilars, and increased spending in biosimilar product research & development are boosting the market growth in the country. The growing incidence of chronic diseases, on the other hand, has attracted growing attention in novel disease-management medicines, which is positively influencing the Latin American protein A Resin Market.

KEY MARKET PLAYERS:

A few prominent companies operating in the Latin America Protein A Resins Market profiled in the report are GE Healthcare, Repligen Corporation, Novasep, Tosoh Bioscience, GenScript, Thermo Fisher Scientific EMD Millipore, and Expedeon Ltd.